Morepen Laboratories Ltd
NSE: MOREPENLAB BSE: 500288
₹43.67
(-2.19%)
Wed, 04 Mar 2026, 06:14 pm
Market Cap23.99B
PE Ratio24.06
Dividend0.46
Health Technology
Pharmaceuticals: Major
24.5KMorepen Laboratories Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.24B | 1.57B | 1.42B | 1.81B | 2.08B | 2.25B | 2.80B | 3.18B | 3.52B | 3.85B | 4.69B | 5.88B | 5.99B | 7.58B | 8.41B | 11.78B | 15.44B | 14.14B | 16.82B | 18.07B |
| Gross profit | -436.10M | -1.34B | -595.26M | -469.64M | -43.97M | -141.26M | -10.70M | 209.30M | 330.10M | 397.60M | 631.15M | 1.03B | 1.02B | 1.03B | 1.14B | 2.08B | 2.65B | 2.19B | 3.26B | 3.17B |
| Operating expenses (excl. COGS) | -43.72M | -48.18M | -38.47M | -51.90M | -361.10M | -312.44M | -369.40M | -433.40M | -445.50M | -463.10M | -530.62M | -834.06M | -791.94M | -865.03M | -941.21M | -1.15B | -1.40B | -1.71B | -2.09B | -1.76B |
| Selling/general/admin expenses, total | — | — | — | — | -272.26M | -221.19M | -342.60M | -403.90M | -430.40M | -451.00M | -517.09M | -810.21M | -778.12M | -850.90M | -923.98M | -1.13B | -1.38B | -1.68B | -2.07B | -1.75B |
| Research & development | -13.13M | -15.35M | -10.81M | -13.78M | -17.03M | -14.94M | -15.20M | -4.80M | -3.80M | -3.10M | -4.65M | -4.14M | -5.04M | -9.59M | -25.47M | -56.46M | -30.08M | -30.69M | -51.98M | -36.94M |
| Selling/general/admin expenses, other | — | — | — | — | -255.23M | -206.25M | -327.40M | -399.10M | -426.60M | -447.90M | -512.44M | -806.07M | -773.08M | -841.31M | -898.51M | -1.07B | -1.35B | -1.65B | -2.02B | -1.71B |
| Other operating expenses, total | -43.72M | -48.18M | -38.47M | -51.90M | -88.84M | -91.25M | -26.80M | -29.50M | -15.10M | -12.10M | -13.54M | -23.86M | -13.82M | -14.13M | -17.24M | -28.32M | -17.24M | -22.73M | -16.42M | -11.75M |
| Operating income | -479.82M | -1.39B | -633.73M | -521.54M | -405.07M | -453.70M | -380.10M | -224.10M | -115.40M | -65.50M | 100.53M | 196.76M | 226.32M | 166.79M | 194.80M | 924.27M | 1.26B | 484.61M | 1.17B | 1.41B |
| Non-operating income, total | 74.64M | 53.69M | 85.11M | 105.49M | 342.66M | -22.61M | 144.40M | 18.90M | 88.00M | 88.30M | 26.12M | 39.54M | 71.39M | 124.98M | 196.28M | 60.85M | 11.60M | 72.94M | 184.20M | 144.06M |
| Interest expense, net of interest capitalized | -6.05M | -59.93M | -100.36M | -20.11M | -35.66M | -62.66M | -79.60M | -116.30M | -99.20M | -86.60M | -105.04M | -75.61M | -43.57M | -21.10M | -19.84M | -17.88M | -24.26M | -19.81M | -37.10M | -65.92M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 80.69M | 123.60M | 54.08M | 45.17M | 39.74M | 40.05M | 103.60M | 104.40M | 158.20M | 174.90M | 175.16M | 115.15M | 114.96M | 146.08M | 216.12M | 221.48M | 229.90M | 92.75M | 221.31M | 209.99M |
| Non-operating interest income | 539.00K | 563.00K | 4.51M | 11.00M | 500.00K | 1.81M | 1.00M | 1.30M | 10.50M | 5.80M | 1.84M | 1.03M | 1.21M | 8.22M | 41.96M | 21.34M | 13.30M | 16.57M | 25.04M | 44.72M |
| Miscellaneous non-operating expense | 80.15M | 123.04M | 49.57M | 34.17M | 39.24M | 38.24M | 102.60M | 103.10M | 147.70M | 169.10M | 173.31M | 114.12M | 113.75M | 137.85M | 174.16M | 200.14M | 216.60M | 76.18M | 196.26M | 165.26M |
| Unusual income/expense | — | -9.99M | 131.39M | 80.43M | 338.58M | — | 120.40M | 30.80M | 29.00M | — | -44.00M | — | — | — | 0 | -142.75M | -194.04M | 0 | 0 | 0 |
| Pretax income | -405.19M | -1.33B | -548.63M | -416.05M | -62.41M | -476.31M | -235.70M | -205.20M | -27.40M | 22.80M | 126.64M | 236.30M | 297.71M | 291.77M | 391.08M | 985.12M | 1.27B | 557.55M | 1.35B | 1.55B |
| Taxes | 4.69M | -253.37M | 0 | -3.25M | -268.00K | 6.84M | -600.00K | -50.00K | -100.00K | -1.40M | 1.35M | 0 | 0 | -3.36M | -55.29M | -14.21M | -250.21M | -170.80M | -387.95M | -370.94M |
| Non-controlling/minority interest | 480.00K | 1.98M | -17.00K | 1.71M | 513.00K | 31.00K | -200.00K | 40.00K | -200.00K | 0 | 7.00K | 45.00K | -1.79M | 89.00K | 3.00K | -41.00K | 14.00K | -3.00K | -4.60M | 50.00K |
| After tax other income/expense | -5.11M | 0 | 0 | — | — | — | 0 | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -405.12M | -1.58B | -548.64M | -417.58M | -62.17M | -469.44M | -236.50M | -205.21M | -27.70M | 21.40M | 128.00M | 236.35M | 295.91M | 288.49M | 335.79M | 970.86M | 1.02B | 386.75M | 961.60M | 1.18B |
| Net income | -405.12M | -1.58B | -548.64M | -417.58M | -62.17M | -469.44M | -236.50M | -205.21M | -27.70M | 21.40M | 128.00M | 236.35M | 295.91M | 288.49M | 335.79M | 970.86M | 1.02B | 386.75M | 961.60M | 1.18B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 6.41M | 0 | 5.00M | 5.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -405.12M | -1.58B | -548.64M | -417.58M | -62.17M | -469.44M | -242.91M | -205.21M | -32.70M | 16.40M | 128.00M | 236.35M | 295.91M | 288.49M | 335.79M | 970.86M | 1.02B | 386.75M | 961.60M | 1.18B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 90.81M | -789.05M | -66.11M | -160.00K | 75.13M | 27.85M | 100.50M | 233.90M | 343.00M | 321.20M | 452.48M | 535.80M | 569.54M | 565.82M | 563.86M | 1.23B | 1.53B | 763.91M | 1.50B | 1.70B |
| EBIT | -479.82M | -1.39B | -633.73M | -521.54M | -405.07M | -453.70M | -380.10M | -224.10M | -115.40M | -65.50M | 100.53M | 196.76M | 226.32M | 166.79M | 194.80M | 924.27M | 1.26B | 484.61M | 1.17B | 1.41B |
| Total operating expenses | -1.72B | -2.95B | -2.06B | -2.33B | -2.49B | -2.71B | -3.18B | -3.41B | -3.64B | -3.91B | -4.59B | -5.68B | -5.76B | -7.41B | -8.21B | -10.86B | -14.18B | -13.66B | -15.65B | -16.66B |
| Prepaid expenses | 2.82M | 830.00K | 1.14M | 1.64M | 1.83M | 1.91M | 2.30M | 1.20M | 4.90M | 3.50M | 97.31M | 4.75M | 7.89M | 185.78M | 14.06M | 11.80M | 26.48M | 45.30M | 100.71M | 691.84M |
| Deferred income, current | — | — | — | — | — | — | — | — | 75.50M | 53.60M | 34.28M | 12.47M | 27.11M | 23.99M | 62.06M | 18.54M | 56.25M | 14.62M | 15.38M | 167.51M |
| Capital and operating lease obligations | 0 | 494.00K | 1.00M | 3.78M | — | — | 0 | 0 | 0 | 0 | 12.20M | 29.47M | 29.47M | 0 | 9.25M | 8.28M | 13.21M | 9.34M | 33.64M | 134.84M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 116.67M | 122.56M | 126.33M | 226.19M |
| Deferred income, non-current | — | — | — | — | — | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority interest | -1.19M | -2.86M | -2.89M | -3.63M | -4.38M | -4.39M | -4.20M | -4.30M | -4.00M | -4.00M | -6.29M | -6.34M | -4.54M | -4.63M | -4.63M | -4.59M | -4.61M | -4.60M | 0 | 307.27M |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | 0 | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800